Title:
COMPOUND ACTING AS IMMUNOMODULATOR, PREPARATION METHOD THEREFOR AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/114477
Kind Code:
A1
Abstract:
The present invention relates to a compound represented by the formula (II), the pharmaceutically acceptable salt thereof, and the uses of the compound acting as an S1P1 agonist.
Inventors:
LU HONGFU (CN)
XING WEIQIANG (CN)
PENG JIANBIAO (CN)
GUO HAIBING (CN)
XING WEIQIANG (CN)
PENG JIANBIAO (CN)
GUO HAIBING (CN)
Application Number:
PCT/CN2019/123514
Publication Date:
June 11, 2020
Filing Date:
December 06, 2019
Export Citation:
Assignee:
SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD (CN)
JIANGXI JEMINCARE GROUP CO LTD (CN)
JIANGXI JEMINCARE GROUP CO LTD (CN)
International Classes:
C07D205/04; A61K31/397; A61P3/10; A61P29/00; A61P31/00; A61P31/12
Domestic Patent References:
| WO2004103306A2 | 2004-12-02 |
Foreign References:
| CN1787817A | 2006-06-14 | |||
| CN102387704A | 2012-03-21 | |||
| CN1921863A | 2007-02-28 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: BASIS SUBSET FEEDBACK FOR CHANNEL STATE INFORMATION ENHANCEMENT
Next Patent: CD3 ANTIBODY AND PHARMACEUTICAL USE THEREOF
Next Patent: CD3 ANTIBODY AND PHARMACEUTICAL USE THEREOF